Multidisciplinary Epidemiology and Translational Research in Intensive Care, Emergency and Perioperative Medicine (METRIC-EPM), Mayo Clinic, Rochester, MN, USA.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Lung. 2021 Oct;199(5):439-445. doi: 10.1007/s00408-021-00479-x. Epub 2021 Sep 29.
Lack of a pragmatic outcome measures for acute respiratory distress syndrome (ARDS) resolution is a barrier to meaningful interventional trials of novel treatments. We evaluated a pragmatic, electronic health record (EHR)-based approach toward the clinical assessment of a novel outcome measure: ICU ARDS resolution.
We conducted a retrospective observational cohort study evaluating adult patients with moderate-severe ARDS admitted to the medical intensive care unit (ICU) at Mayo Clinic in Rochester, MN, from January 2001 through December 2010. We compared the association of ICU ARDS resolution vs non-resolution with mortality. ICU ARDS resolution was defined as improvement in P/F > 200 for at least 48 h or (if arterial blood gas unavailable) SpO:FiO (S/F) > 235, or discharge prior to 48 h from first P/F > 200 without subsequent decline in P/F, as documented in EHR.
Of the 254 patients included, ICU ARDS resolution was achieved in 179 (70%). Hospital mortality was lower in patients who met ICU ARDS resolution criteria as compared to those who did not (23% vs. 41%, p < 0.01). After adjusting for age, gender, and illness severity, the patients who met ICU ARDS resolution criteria had lower odds of hospital mortality [odds ratio 0.47, 95% CI 0.25-0.86; p = 0.015].
The electronic health record-based pragmatic measure of ICU ARDS resolution is associated with patient outcomes and may serve as an intermediate outcome assessing novel mechanistic treatments.
急性呼吸窘迫综合征(ARDS)缓解缺乏实用的结局指标,这是新型治疗方法进行有意义干预试验的障碍。我们评估了一种实用的基于电子健康记录(EHR)的方法,用于评估一种新型结局指标:ICU-ARDS 缓解。
我们进行了一项回顾性观察队列研究,评估了 2001 年 1 月至 2010 年 12 月期间在明尼苏达州罗切斯特市梅奥诊所内科重症监护病房(ICU)收治的中重度 ARDS 成年患者。我们比较了 ICU-ARDS 缓解与非缓解与死亡率的相关性。ICU-ARDS 缓解定义为至少 48 小时内 P/F 改善>200 或(如果动脉血气不可用)SpO2:FiO2(S/F)>235,或在首次 P/F>200 后 48 小时内出院且此后 P/F 无下降,这在 EHR 中有记录。
在纳入的 254 例患者中,179 例(70%)达到 ICU-ARDS 缓解。与未达到 ICU-ARDS 缓解标准的患者相比,达到 ICU-ARDS 缓解标准的患者的住院死亡率较低(23%比 41%,p<0.01)。在调整年龄、性别和疾病严重程度后,达到 ICU-ARDS 缓解标准的患者的住院死亡率较低[比值比 0.47,95%置信区间 0.25-0.86;p=0.015]。
基于 EHR 的 ICU-ARDS 缓解实用测量方法与患者结局相关,可作为评估新型机制治疗方法的中间结局。